Lawrenceville, NJ, United States of America

Mark Kowala


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Mark Kowala

Introduction

Mark Kowala is an accomplished inventor based in Lawrenceville, NJ (US). He has made significant contributions to the field of medicine, particularly in the area of cholesterol management. His innovative approach has the potential to impact the health of many individuals suffering from high cholesterol levels.

Latest Patents

Mark Kowala holds a patent for a method aimed at lowering serum cholesterol. This method involves administering a phosphorus-containing ACE inhibitor, such as fosinopril or ceronapril, either alone or in combination with a cholesterol-lowering drug like pravastatin. This innovative approach not only targets cholesterol levels but also aims to inhibit fatty streak lesions associated with atherosclerosis.

Career Highlights

Kowala is currently employed at E.R. Squibb & Sons, Inc., where he continues to develop and refine his ideas. His work at this esteemed company has allowed him to collaborate with other talented professionals in the field.

Collaborations

Some of his notable coworkers include A K Aberg and Patricia Ferrer. Their combined expertise contributes to the innovative environment at E.R. Squibb & Sons, Inc.

Conclusion

Mark Kowala's contributions to the field of medicine through his patent for lowering serum cholesterol demonstrate his commitment to improving health outcomes. His work continues to inspire innovation in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…